Background: Increasingly, drug and device clinical trials are tracking activity levels and other quality of life indices as endpoints for therapeutic efficacy. Trials have traditionally required inter
Yrs.: Years. *Percentage of patients requiring insulin therapy in metformin group. BMI: Body mass index. OGTT: Oral glucose tolerance test. F: Fasting. **Two different cutoff values were taken due to
Figures in brackets are standard deviation of the mean. eGFR = estimated glomerular filtration rate, 25 (OH) D = 25 hydroxy vitamin D, Hb = haemaglobin, PTH = parathyroid hormone, CRP = C rea